Effect of Photodynamic Therapy on the microRNA Level in Breast Cancer Tissues of Female Wistar Rats

O V Kazakov1, A V Kabakov2, A F Poveshchenko2

  • 1Research Institute of Clinical and Experimental Lymphology - Affiliated Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia. kazakoff_oleg@mail.ru.

Insights

Photodynamic therapy reduced oncogenic microRNAs (miR-21, miR-221, miR-27a) in rat breast tumors. However, tumor-suppressing miR-429 levels remained low after treatment, indicating potential for further therapeutic development.

Area of Science:

  • Biomedical Sciences
  • Molecular Biology
  • Oncology

Background:

  • MicroRNAs play crucial roles in gene regulation and are implicated in various cancers, including breast cancer.
  • Specific microRNAs like miR-21, miR-221, miR-27a, and miR-429 have been associated with tumor development and suppression.
  • Photodynamic therapy (PDT) is a treatment modality that uses light and a photosensitizer to destroy cancer cells.

Purpose of the Study:

  • To investigate the expression profiles of key microRNAs (miR-21, miR-221, miR-27a, miR-429) in normal and breast tumor tissues of Wistar rats.
  • To evaluate the impact of photodynamic therapy on the expression levels of these microRNAs in a rat breast cancer model.

Main Methods:

  • Quantitative real-time PCR was used to measure microRNA expression levels.
  • Breast tissue samples were collected from normal rats, untreated tumor-bearing rats, and rats that underwent photodynamic therapy.
  • Comparative analysis of microRNA expression was performed across different experimental groups.

Main Results:

  • In breast tumor tissues, oncogenic microRNAs (miR-21, miR-221, miR-27a) showed significantly increased expression, while tumor-suppressing miR-429 was downregulated compared to normal tissues.
  • Following photodynamic therapy, a notable suppression in the expression of oncogenic microRNAs (miR-21, miR-221, miR-27a) was observed.
  • The expression level of tumor-suppressing miR-429 in treated breast tumor tissues remained low, similar to the untreated tumor group.

Conclusions:

  • Photodynamic therapy effectively downregulates oncogenic microRNAs involved in breast cancer progression.
  • The persistent low expression of tumor-suppressing miR-429 after PDT suggests it may not be a direct target or biomarker for PDT efficacy in this model.
  • Further research is warranted to explore the role of miR-429 and potential combination therapies to restore its tumor-suppressive function.

Related Concept Videos